Page last updated: 2024-11-05

5-methylurapidil and Hypertrophy, Right Ventricular

5-methylurapidil has been researched along with Hypertrophy, Right Ventricular in 1 studies

Hypertrophy, Right Ventricular: Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.

Research Excerpts

ExcerptRelevanceReference
"In rats, injection of monocrotaline (MCT) causes pulmonary hypertension that leads to right ventricular failure."3.71Changes in alpha(1)-adrenergic vascular reactivity in monocrotaline-treated rats. ( Brodde, OE; Dhein, S; Giessler, C; Heinroth-Hoffmann, I; Leineweber, K; Seyfarth, T, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dhein, S1
Giessler, C1
Heinroth-Hoffmann, I1
Leineweber, K1
Seyfarth, T1
Brodde, OE1

Other Studies

1 other study available for 5-methylurapidil and Hypertrophy, Right Ventricular

ArticleYear
Changes in alpha(1)-adrenergic vascular reactivity in monocrotaline-treated rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2002, Volume: 365, Issue:2

    Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agon

2002